[{"address1": "Perryville III Building", "address2": "Suite 220 53 Frontage Road", "city": "Hampton", "state": "NJ", "zip": "08827", "country": "United States", "phone": "908 200 7500", "fax": "908 454 1911", "website": "https://www.celldex.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey.", "fullTimeEmployees": 186, "companyOfficers": [{"maxAge": 1, "name": "Mr. Anthony S. Marucci M.B.A.", "age": 62, "title": "Founder, President, CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1325365, "exercisedValue": 0, "unexercisedValue": 5079544}, {"maxAge": 1, "name": "Dr. Tibor  Keler Ph.D.", "age": 65, "title": "Founder, Chief Scientific Officer & Executive VP", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 835800, "exercisedValue": 0, "unexercisedValue": 3159504}, {"maxAge": 1, "name": "Mr. Sam  Martin CPA", "age": 53, "title": "Senior VP, CFO, Secretary & Treasurer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 706094, "exercisedValue": 1494160, "unexercisedValue": 1095699}, {"maxAge": 1, "name": "Ms. Elizabeth  Crowley", "age": 52, "title": "Chief Product Development Officer & Senior VP", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 690938, "exercisedValue": 2384608, "unexercisedValue": 826654}, {"maxAge": 1, "name": "Dr. Margo  Heath-Chiozzi M.D.", "age": 66, "title": "Senior Vice President of Regulatory Affairs", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 699452, "exercisedValue": 2532308, "unexercisedValue": 763424}, {"maxAge": 1, "name": "Prof. Joseph P. Schlessinger Ph.D.", "age": 79, "title": "Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1945, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Freddy A. Jimenez Esq.", "age": 55, "title": "Senior VP & General Counsel", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 579698, "exercisedValue": 0, "unexercisedValue": 944122}, {"maxAge": 1, "name": "Dr. Ronald A. Pepin Ph.D.", "age": 68, "title": "Chief Business Officer & Senior VP", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 441839, "exercisedValue": 0, "unexercisedValue": 2023453}, {"maxAge": 1, "name": "Dr. Richard M. Wright Ph.D.", "age": 60, "title": "Chief Commercial Officer & Senior VP", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 446448, "exercisedValue": 0, "unexercisedValue": 3516162}, {"maxAge": 1, "name": "Dr. Diane C. Young M.D.", "age": 67, "title": "Senior VP & Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 696453, "exercisedValue": 0, "unexercisedValue": 2722212}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 5, "shareHolderRightsRisk": 1, "overallRisk": 3, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.avantimmune.com/", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 25.25, "open": 25.68, "dayLow": 25.237, "dayHigh": 26.36, "regularMarketPreviousClose": 25.25, "regularMarketOpen": 25.68, "regularMarketDayLow": 25.237, "regularMarketDayHigh": 26.36, "payoutRatio": 0.0, "beta": 1.193, "forwardPE": -8.092879, "volume": 951476, "regularMarketVolume": 951476, "averageVolume": 1254879, "averageVolume10days": 1225610, "averageDailyVolume10Day": 1225610, "bid": 26.03, "ask": 26.21, "bidSize": 1, "askSize": 1, "marketCap": 1735867008, "fiftyTwoWeekLow": 14.4, "fiftyTwoWeekHigh": 34.5, "allTimeHigh": 3375.0, "allTimeLow": 1.5, "priceToSalesTrailing12Months": 299.80432, "fiftyDayAverage": 23.2616, "twoHundredDayAverage": 21.94505, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1108561024, "profitMargins": 0.0, "floatShares": 53206915, "sharesOutstanding": 66406544, "sharesShort": 6581143, "sharesShortPriorMonth": 7312348, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.0991, "heldPercentInsiders": 0.00191, "heldPercentInstitutions": 1.11268, "shortRatio": 4.06, "shortPercentOfFloat": 0.1171, "impliedSharesOutstanding": 68133169, "bookValue": 9.871, "priceToBook": 2.6481612, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -199608992, "trailingEps": -3.01, "forwardEps": -3.23, "lastSplitFactor": "1:15", "lastSplitDate": 1549843200, "enterpriseToRevenue": 191.461, "enterpriseToEbitda": -4.791, "52WeekChange": -0.2309503, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 26.14, "targetHighPrice": 90.0, "targetLowPrice": 30.0, "targetMeanPrice": 56.25, "targetMedianPrice": 59.5, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 12, "totalCash": 630337024, "totalCashPerShare": 9.492, "ebitda": -231404992, "totalDebt": 3031000, "quickRatio": 19.125, "currentRatio": 19.671, "totalRevenue": 5790000, "debtToEquity": 0.462, "revenuePerShare": 0.087, "returnOnAssets": -0.19079, "returnOnEquity": -0.27175, "grossProfits": -193222000, "freeCashflow": -110811752, "operatingCashflow": -186190000, "revenueGrowth": -0.708, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -87.47534, "financialCurrency": "USD", "symbol": "CLDX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekLowChange": 11.74, "fiftyTwoWeekLowChangePercent": 0.81527776, "fiftyTwoWeekRange": "14.4 - 34.5", "fiftyTwoWeekHighChange": -8.360001, "fiftyTwoWeekHighChangePercent": -0.24231885, "fiftyTwoWeekChangePercent": -23.09503, "dividendDate": 1549843200, "earningsTimestampStart": 1762372800, "earningsTimestampEnd": 1762372800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.01, "epsForward": -3.23, "epsCurrentYear": -3.41826, "priceEpsCurrentYear": -7.6471653, "fiftyDayAverageChange": 2.878399, "fiftyDayAverageChangePercent": 0.12374036, "twoHundredDayAverageChange": 4.19495, "twoHundredDayAverageChangePercent": 0.19115701, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Celldex Therapeutics, Inc.", "longName": "Celldex Therapeutics, Inc.", "exchange": "NCM", "messageBoardId": "finmb_9620565", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.52475, "regularMarketPrice": 26.14, "corporateActions": [], "postMarketTime": 1758922180, "regularMarketTime": 1758916801, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 516547800000, "postMarketChangePercent": -1.6449897, "postMarketPrice": 25.71, "postMarketChange": -0.4300003, "regularMarketChange": 0.889999, "regularMarketDayRange": "25.237 - 26.36", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1254879, "displayName": "Celldex Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]